- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2021 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Spondyloarthritis
Secukinumab Improves Spinal Pain in Patients With Axial Spondyloarthritis
October 26, 2021
Chronic back pain, a common symptom of axial spondyloarthritis that increases disease burden and reduces quality of life, may be improved by subcutaneous injection of secukinumab 150 mg or 300 mg.
Upadacitinib Meets Primary and Most Ranked Secondary Endpoints in 2 Phase 3 Clinical Trials
October 08, 2021
Upadacitinib achieved positive results from both Phase 3 SELECT-AXIS clinical trials, which focused on patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
Higher Disease Burden Seen in Women With Axial Spondyloarthritis
October 07, 2021
Limited information is available on the overall disease burden of axial spondyloarthritis (axSpA) in women, as they are generally underrepresented in clinical studies.
Ixekizumab Improves Fatigue in Patients With Non-Radiographic Axial Spondyloarthritis
October 05, 2021
“Many patients with axial spondyloarthritis who receive treatment still experience disease-related burdens in different aspects of health-related quality of life,” investigators stated.
Patients With Axial Spondyloarthritis Less Likely to Engage in Physical Activity
August 31, 2021
"Physical activity and exercise have been shown to improve general well-being and reduce cardiovascular disease risk in the general population," investigators stated. "Despite these recommendations, studies show that levels of PA are reduced among patients with axial spondyloarthritis.”
Epionics SPINE Device Successfully Assesses Spinal Mobility in Patients With Axial Spondyloarthritis
August 24, 2021
The Epionics SPINE is an innovative tool to assess the spinal mobility of patients with axial spondyloarthritis.
Jeffrey Stark, MD: New Sub-Category for Non-Radiographical Axial Spondyloarthritis
June 15, 2021
Jeffrey Stark, MD, discusses the statement UCB issued endorsing the creation of a new sub-category (M.45A) for non-radiographical axial spondyloarthritis (nr-axSpA).
Jessica Walsh, MD: Patient Perspectives of Biologic Treatments for Axial Spondyloarthritis
June 09, 2021
Rheumatology Network spoke with Jessica Walsh, MD, to discuss her study, “Patient perspectives of biologic treatments for axial spondyloarthritis: satisfaction, wear-off between doses, and use of supplemental medications."
Women With Axial Spondyloarthritis Have Higher Disease Burden Than Men
April 22, 2021
Investigators discovered that women with axial spondyloarthritis (axSpA) have an overall higher disease burden and more peripheral manifestations when compared with men. They further theorized that awareness of these differences and the way the condition presents differently in both sexes may be used to more easily identify axSpA and improve disease management.
Recognizing Axial Spondyloarthritis in Primary Care
October 15, 2020
Back pain is the second leading symptom prompting a visit to a primary care physician. Here, we highlight a review of axial spondyloarthritis from Mayo Clinic Proceedings. The review aims to help primary care physicians detect this condition and know when to refer to a rheumatologist.